Companies: 10,795·Total market cap: $144.5T

DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

DMACNASDAQHealthcare● Active

$5.61

$-0.03(-0.53%)

Market Cap$302285313

P/E Ratio—

52W High$10.4195

52W Low$3.475

Avg Volume191K

Open$5.68

Beta1.00

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

DiaMedica Therapeutics Inc.（DMAC）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · DMAC · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.71Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding47.0MShares outstanding history

Next EarningsAug 11, 2026Est.Earnings history

探索 DiaMedica Therapeutics Inc. 数据

分析师预测$8 · Buy

股息不分红

盈利EPS $-0.70-16.67%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$32.8M▼ 34.05% YoY

202320242025

FY 2025EPS$-0.70▼ 16.67% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$35.1MEPS: $-0.71View income statement →

分析师评级与目标价

Buy6 位分析师

Strong Buy

0

Buy

6

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$7.00Low

$5.61Current

$8.33Avg Target上涨空间 48.48%

$10.00High

合计: 6 · 买入占比: 100.0%

根据过去 3 个月内 6 位华尔街分析师，DMAC 共识评级为 Buy，12 个月平均目标价 $8.33 （较现价 $5.61 上涨空间 48.48%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

DiaMedica Therapeutics Inc.

$5.61-0.53%$302.3M #2

Altimmune, Inc.

$2.73+0.74%$240.9M #3

$5.12-3.21%$612.3M #4

DBV Technologies S.A.

$16.00-3.56%$382.7M #5

Alpha Tau Medical Ltd.

$9.28-0.75%$838.2M #6

Design Therapeutics, Inc.

$10.46-1.78%$653.3M

股票表现

1D-0.53%

1W-0.88%

1M-11.23%

3M-27.24%

YTD-29.52%

1Y+37.50%

5Y-33.37%

关于 DiaMedica Therapeutics Inc.

CEODietrich John Pauls

IPO DateAug 3, 2012

Employees27

CountryUS

Websitediamedica.com

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, …

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

DiaMedica Therapeutics Inc.（DMAC）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 3, 2012 在 NASDAQ 上市。截至最近交易日，DMAC 股价为 $5.61，市值约为 $302.3M。过去12个月累计回报 +37.50%，年初至今回报 -29.52%。

根据 6 位华尔街分析师，DiaMedica Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $8.33。2025 财年 DiaMedica Therapeutics Inc. 营收 —，净利润 -$32.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，DiaMedica Therapeutics Inc.（DMAC）股价为 $5.61，在 NASDAQ 上市，52周区间为 $3.48 – $10.42。

DMAC 最新股价DMAC quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议